Wegovy and Zepbound are FDA-approved specifically for weight management
Then the market hit an inflection point: GLP-1 stopped being metabolic medicine and became a category-defining obesity engine, with downstream effects across payer policy, manufacturing capacity, and portfolio strategy
Small, frequent, protein-forward meals work better than large traditional breakfasts when taking Ozempic, Wegovy, Mounjaro, or Zepbound
Heres what well cover in this blog post: What medications interact with GLP-1s Whether its safe to take these medications with GLP-1s How to stay safe with on GLP-1 therapy GLP-1 receptor agonists, such as Semaglutide and Tirzepatide, have made managing weight loss and blood sugar levels much simpler
Most are manageable, especially when treatment starts at a low dose and builds up gradually
Those working with tirzepatide reconstitution should follow established protocols to ensure consistent potency and predictable effects